Switching to tenofovir suppresses hepatitis B in HIV/HBV co-infected people
Long-acting integrase inhibitor S/GSK1265744 active against multiple HIV subtypes
Dolutegravir combo beats Atripla for effectiveness and tolerability
Progression of anal neoplasia is common among gay men with HIV
Sofosbuvir appears safe and effective for HIV/HCV co-infected people
Integrated analysis shows 'Quad' pill has potent activity with fewer side-effects
Hepatitis B vaccine is effective for up to 15 years
Long-acting fusion inhibitor albuvirtide looks promising in early studies
HIV-positive people have heart attacks younger but receive later care
